Sofosbuvir and Hepatitis - a phase IV clinical study of FDA data

Summary:

Hepatitis is reported as a side effect among people who take Sofosbuvir (sofosbuvir), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Daklinza, and have Hepatitis c.

The phase IV clinical study analyzes which people have Hepatitis when taking Sofosbuvir. It is created by eHealthMe based on reports of 9,193 people who have side effects when taking Sofosbuvir from the FDA, and is updated regularly.

What is Sofosbuvir?

Sofosbuvir has active ingredients of sofosbuvir. eHealthMe is studying from 9,194 Sofosbuvir users. Check the latest studies of Sofosbuvir.

What is Hepatitis?

Hepatitis (inflammation of the liver) is found to be associated with 1,462 drugs and 1,523 conditions by eHealthMe. Check the latest studies of Hepatitis.

On Jul, 21, 2026

9,193 people reported to have side effects when taking Sofosbuvir.
Among them, 16 people (0.17%) have Hepatitis.

Among these 16 people:

How long have people been on Sofosbuvir when they have Hepatitis? *

What is the gender of people who have Hepatitis when taking Sofosbuvir? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Hepatitis when taking Sofosbuvir? *

What are other drugs people take besides Sofosbuvir? *

Daklinza: 4 people, 25.00%
Rebetol: 1 person, 6.25%
Olysio: 1 person, 6.25%
Diovan: 1 person, 6.25%

What are other side effects people have besides Hepatitis? *

Anaemia (lack of blood): 2 people, 12.50%
Muscle Aches (muscle pain): 2 people, 12.50%
Hepatorenal Syndrome (renal failure in patients with advanced chronic liver disease): 2 people, 12.50%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%
Insomnia (sleeplessness): 2 people, 12.50%
Itching: 2 people, 12.50%
Dizziness: 2 people, 12.50%
Headache (pain in head): 2 people, 12.50%
Nausea (feeling of having an urge to vomit): 2 people, 12.50%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 12.50%

What are the existing conditions these people have? *

Hepatitis C: 9 people, 56.25%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 25.00%
Immunodeficiency Disorders: 2 people, 12.50%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 6.25%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sofosbuvir and have Hepatitis?

- Check whether Hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sofosbuvir:

Sofosbuvir (9,194 reports)

Hepatitis treatments and more:

Hepatitis (31,197 reports)

Browse all side effects of Sofosbuvir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis:

Hepatitis (1,463 drugs)

Browse all the conditions that are associated with Hepatitis:

Hepatitis (1,523 conditions)

Related publications that referenced our studies

Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sofosbuvir) and Sofosbuvir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.